{
  "table_name": "EWING_SARCOM_RESEC",
  "description": "Stores data for College of American Pathologists (CAP) form 76019-EWING SARCOMA/PRIMITIVE NEUROECTODERMAL TUMOR: Resection.",
  "primary_key": {
    "column_name": "RESULT_ID",
    "ordinal_position": "1"
  },
  "columns": [
    {
      "index": 2,
      "name": "RESULT_ID",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "The unique identifier for the result record."
    },
    {
      "index": 7,
      "name": "TUMOR_SITE_SPECIFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify tumor site."
    },
    {
      "index": 12,
      "name": "CAP_COMMENTS",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: General comments."
    },
    {
      "index": 17,
      "name": "SPEC_PROC_SPECIFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify the Specimen Procedure."
    },
    {
      "index": 22,
      "name": "TUMOR_SIZE_GREAT",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Tumor Greatest Size."
    },
    {
      "index": 27,
      "name": "TUMOR_SIZE_ADDL",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Tumor Size (length)."
    },
    {
      "index": 32,
      "name": "TUMOR_SIZE_ADDL2",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Tumor Size (width)."
    },
    {
      "index": 37,
      "name": "TUMOR_SIZE_SPECIFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Tumor Size."
    },
    {
      "index": 42,
      "name": "SPEC_PROC_AMPU_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specimen Procedure Amputation Specify."
    },
    {
      "index": 47,
      "name": "EXT_OSSEOS_TMR_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Extent of Osseous Tumors."
    },
    {
      "index": 52,
      "name": "EXTRAOSS_TMR_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Extent of Primary Extraosseous Tumors."
    },
    {
      "index": 57,
      "name": "SPECIFIC_MARGINS",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specific Margins."
    },
    {
      "index": 62,
      "name": "DIST_CLSEST_BNE_MRG",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Distance of Tumor from Closest Bone Margin."
    },
    {
      "index": 67,
      "name": "DIST_CLSEST_SFT_TIS",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Distance of Tumor from Closest Soft Tissue Margin."
    },
    {
      "index": 72,
      "name": "NECROSIS_POSTCHEM_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Necrosis Postchemotherapy.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nNecrosis not identified\n\n\nNecrosis present\n\n\nCannot be determined\n\n\nNot applicable"
    },
    {
      "index": 83,
      "name": "NECROSIS_EXTENT",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Necrosis Extent."
    },
    {
      "index": 88,
      "name": "CYTOGENETICS_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Cytogenetics.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nSpecify\n\n\nPerformed, see separate report\n\n\nPerformed\n\n\nNot performed"
    },
    {
      "index": 99,
      "name": "CYTOGENETICS_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify cytogenetics."
    },
    {
      "index": 104,
      "name": "MOLECULAR_PATH_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Molecular Pathology.\n\n\n The category values for this column were already listed for column: CYTOGENETICS_C_NAME"
    },
    {
      "index": 110,
      "name": "MOLECULAR_PATH_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify molecular pathology."
    },
    {
      "index": 115,
      "name": "STG_OSS_EXTRA_TMR_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Stage for Osseous and Extraosseous Tumors.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nFor Primary Osseous Tumors (Note G)\n\n\nFor Primary Extraosseous Tumors (Note H)"
    },
    {
      "index": 124,
      "name": "PT_PRM_EXTRAOS_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Primary Tumor (pT) for Primary Extraosseous Tumors.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\npTX: Primary tumor cannot be assessed\n\n\npT0: No evidence of primary tumor\n\n\npT1a: Tumor 5 cm or less in greatest dimension, superficial tumor\n\n\npT1b: Tumor 5 cm or less in greatest dimension, deep tumor\n\n\npT2a: Tumor more than 5 cm in greatest dimension, superficial tumor\n\n\npT2b: Tumor more than 5 cm in greatest dimension, deep tumor"
    },
    {
      "index": 137,
      "name": "PT_PRM_OSSEOUS_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Primary Tumor (pT) for Primary Osseous Tumors.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\npTX: Primary tumor cannot be assessed\n\n\npT0: No evidence of primary tumor\n\n\npT1: Tumor 8 cm or less in greatest dimension\n\n\npT2: Tumor more than 8 cm in greatest dimension\n\n\npT3: Discontinuous tumors in the primary bone site (not including skip metastases)"
    },
    {
      "index": 149,
      "name": "PM_PRM_EXTRAOS_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Distant Metastasis (pM) for Primary Extraosseous Tumors.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nNot applicable\n\n\ncM0 (i+): No clinical or radiographic evidence of distant metastasis\n\n\npM0: No distant metastasis\n\n\npM1: Distant metastasis\n\n\npM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx\n\n\npM1b: Nonperitoneal metastasis\n\n\npM1: Distant detectable metastasis as determined by classic clinical\n\n\npM1 (IVB): Distant metastasis\n\n\npM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or\n\n\npM1b: Distant metastases outside the lung / pleura\n\n\npM1: Distant metastasis (documented in this specimen)\n\n\npM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes\n\n\npM1b: Metastasis to lung\n\n\npM1c: Metastasis to all other visceral sites or distant metastasis at any site\n\n\npM1a: Nonregional lymph node(s)\n\n\npM1b: Bone(s)\n\n\npM1c: Other site(s) with or without bone disease\n\n\npM1: Metastasis to sites other than CNS\n\n\npM1a: Single lesion\n\n\npM1b: Multiple lesions\n\n\npM1c: CNS metastasis\n\n\npM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement\n\n\npM1e: Leptomeningeal and / or CSF involvement\n\n\npM1a: Non-regional lymph nodes or pulmonary metastasis\n\n\npM1b: Distant metastasis other than to nonregional lymph nodes and lungs\n\n\npM1a (III): Tumor extends to the lungs with or without genital tract involvement\n\n\npM1b (IV): Tumor involves other metastatic sites\n\n\npM1a: Largest diameter of the largest metastasis 3 cm or less\n\n\npM1b: Largest diameter of the largest metastasis 3.1-8.0 cm\n\n\npM1c: Largest diameter of the largest metastasis 8 cm or more\n\n\npM1a: Lung\n\n\npM1b: Metastasis involving distant sites other than lung (including skip metastases)\n\n\nDistant Metastasis present (includes metastasis to lymph nodes)"
    },
    {
      "index": 189,
      "name": "PM_PRM_OSSEOUS_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Distant Metastasis (pM) for Primary Osseous Tumors.\n\n\n The category values for this column were already listed for column: PM_PRM_EXTRAOS_C_NAME"
    },
    {
      "index": 195,
      "name": "REGIONL_LYMPH_ND_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Regional Lymph Nodes (pN).\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\npNX: Cannot be assessed\n\n\npN0: No regional lymph node metastasis\n\n\npN1: Regional lymph node metastasis\n\n\npN1: Metastasis in perirectal lymph nodes\n\n\npN1: Metastasis in 1 to 3 regional lymph nodes\n\n\npN1a: Metastasis in 1 regional lymph node\n\n\npN1b: Metastasis in 2 to 3 regional lymph nodes\n\n\npN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta\n\n\npN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes\n\n\npN1: Regional lymph node metastasis involving 1 to 2 nodes\n\n\npN1 (IIIC): Regional lymph node metastasis\n\n\npN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery\n\n\npN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension\n\n\npN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, \n\n\npN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes\n\n\npN1a: Clinically occult (microscopic) metastasis\n\n\npN1b: Clinically apparent (macroscopic) metastasis\n\n\npN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension\n\n\npN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension\n\n\npN1: Metastasis in 1 to 2 perigastric lymph nodes\n\n\npN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension,\n\n\npN1a: Nodal metastases to Level VI lymph nodes\n\n\npN1b: Metastases to unilateral, bilateral or contralateral cervical \n\n\npN1: Single regional lymph node metastasis in the true pelvis \n\n\npN1 (IVB): Pelvic or inguinal lymph node metastasis\n\n\npN1: Metastasis in regional lymph node or nodes\n\n\npN1: Regional lymph node involvement (preauricular, cervical, submandibular)\n\n\npN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s)\n\n\npN2: Metastasis in 4 or more regional lymph nodes\n\n\npN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd\n\n\npN2a: Metastasis in 4 to 6 regional lymph nodes\n\n\npN2b: Metastasis in 7 or more regional lymph nodes\n\n\npN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho\n\n\npN2: 3 to 6 nodes involved\n\n\npN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n\n\n\npN2: Metastasis in a single ipsilateral lymph node, more than 3 cm\n\n\npN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than\n\n\npN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension\n\n\npN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension\n\n\npN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen.\n\n\npN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s)\n\n\npN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes \n\n\npN2a: Clinically occult (microscopic) metastasis\n\n\npN2b: Clinically apparent (macroscopic) metastasis\n\n\npN2c: Satellite or in-transit metastasis without nodal metastasis\n\n\npN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension\n\n\npN2: Metastasis in a single regional lymph node, more than 2 cm but not more than\n\n\npN2: Metastasis in 3 to 6 perigastric lymph nodes\n\n\npN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm \n\n\npN2: Multiple regional lymph node metastasis in the true pelvis \n\n\npN2: Distant lymph node involvement\n\n\npN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il\n\n\npN3: 7 or more nodes involved\n\n\npN3: Metastasis in a lymph node more than 6 cm in greatest dimension\n\n\npN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or\n\n\npN3: Metastases in the contralateral mediastinal, contralateral internal mammary,\n\n\npN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or\n\n\npN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa\n\n\npN3a: Greater than 6 cm in dimension\n\n\npN3b: Extension to the supraclavicular fossa\n\n\npN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension\n\n\npN3: Metastasis in 7 or more perigastric lymph nodes\n\n\npN3a: Metastasis in 7 to 15 perigastric lymph nodes\n\n\npN3b: Metastasis in 16 or more perigastric lymph nodes\n\n\npN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension\n\n\npN3: Lymph node metastasis to the common iliac lymph nodes\n\n\npN1: One or two regional lymph nodes with the following features\n\n\npN2 (FIGO IIIB): Regional lymph node metastasis with the following features\n\n\npN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis"
    },
    {
      "index": 271,
      "name": "REG_LN_NUM_EXM",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Regional Lymph Nodes Number Examined."
    },
    {
      "index": 276,
      "name": "REG_LN_NUM_INV",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Regional Lymph Nodes Number Involved."
    },
    {
      "index": 281,
      "name": "NONREGION_LYM_ND_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Nonregional Lymph Nodes.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nCannot be assessed\n\n\nNo nonregional lymph node metastasis\n\n\nNonregional lymph node metastasis"
    },
    {
      "index": 291,
      "name": "NONREGION_NUM_EXAM",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Nonregional Lymph Nodes - Number Examined."
    },
    {
      "index": 296,
      "name": "NONREGION_NUM_INVOL",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "CAP synoptic form item: Nonregional Lymph Nodes - Number Involved."
    },
    {
      "index": 301,
      "name": "ADDL_PATH_FIND_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify additional pathologic findings."
    },
    {
      "index": 306,
      "name": "PM_PRM_OSSEOUS_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Distant Metastasis (pM) for Primary Osseous Tumors."
    },
    {
      "index": 311,
      "name": "PM_PRM_EXTRAOS_SPFY",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Specify Distant Metastasis (pM) for Primary Extraosseous Tumors."
    }
  ]
}
